These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18201149)

  • 21. Impact of ketolides on resistance selection and ecologic effects during treatment for respiratory tract infections.
    Nord CE; Farrell DJ; Leclercq R
    Microb Drug Resist; 2004; 10(3):255-63. PubMed ID: 15383171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ketolides--the modern relatives of macrolides : the pharmacokinetic perspective.
    Zeitlinger M; Wagner CC; Heinisch B
    Clin Pharmacokinet; 2009; 48(1):23-38. PubMed ID: 19071882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections.
    Yassin HM; Dever LL
    Expert Opin Investig Drugs; 2001 Feb; 10(2):353-67. PubMed ID: 11178347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-9 Alkenylidine bridged macrolides: WO2008061189. Enanta Pharmaceuticals, Inc.
    Poce G; Cesare Porretta G; Biava M
    Expert Opin Ther Pat; 2009 Jun; 19(6):901-6. PubMed ID: 19473109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telithromycin in lower respiratory tract infections.
    Blasi F; Cazzola M; Tarsia P; Aliberti S; Baldessari C; Valenti V
    Future Microbiol; 2006 Jun; 1(1):7-16. PubMed ID: 17661681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythromycin, Cethromycin and Solithromycin display similar binding affinities to the E. coli's ribosome: A molecular simulation study.
    Nguyen HL; An PH; Thai NQ; Linh HQ; Li MS
    J Mol Graph Model; 2019 Sep; 91():80-90. PubMed ID: 31200217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin.
    Felmingham D; Reinert RR; Hirakata Y; Rodloff A
    J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():25-37. PubMed ID: 12239226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibacterial resistance among children with community-acquired respiratory tract infections (PROTEKT 1999-2000).
    Felmingham D; Farrell DJ; Reinert RR; Morrissey I
    J Infect; 2004 Jan; 48(1):39-55. PubMed ID: 14667791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of the new ketolide telithromycin and other antibiotics against Streptococcus pneumoniae in Belgium.
    Verhaegen J; Verbist L
    Acta Clin Belg; 2001; 56(6):349-53. PubMed ID: 11881319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drugs of the 21st century: telithromycin (HMR 3647)--the first ketolide.
    Ackermann G; Rodloff AC
    J Antimicrob Chemother; 2003 Mar; 51(3):497-511. PubMed ID: 12615850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Telithromycin, a once-a-day ketolide in the treatment of community acquired pneumonia].
    Carbon C
    Presse Med; 2000 Dec; 29(37):2042-3. PubMed ID: 11155730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative in vitro activity of telithromycin and beta-lactam antimicrobials against bacterial pathogens from community-acquired respiratory tract infections: data from the first year of PROTEKT (1999-2000).
    Kohno S; Hoban D;
    J Chemother; 2003 Aug; 15(4):335-41. PubMed ID: 12962361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The emerging new generation of antibiotic: ketolides.
    Zhong P; Shortridge V
    Curr Drug Targets Infect Disord; 2001 Aug; 1(2):125-31. PubMed ID: 12455409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationships of ketolides vs. macrolides.
    Douthwaite S
    Clin Microbiol Infect; 2001; 7 Suppl 3():11-7. PubMed ID: 11523556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ketolides: a new class of antibacterial agents for treatment of community-acquired respiratory tract infections in a primary care setting.
    Clark JP; Langston E
    Mayo Clin Proc; 2003 Sep; 78(9):1113-24. PubMed ID: 12962166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrolides, ketolides, and glycylcyclines: azithromycin, clarithromycin, telithromycin, tigecycline.
    Zuckerman JM; Qamar F; Bono BR
    Infect Dis Clin North Am; 2009 Dec; 23(4):997-1026, ix-x. PubMed ID: 19909895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical management of respiratory tract infections in the community: experience with telithromycin.
    Quintiliani R
    Infection; 2001 Dec; 29 Suppl 2():16-22. PubMed ID: 11785852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telithromycin: the first ketolide for the treatment of respiratory infections.
    Kasbekar N; Acharya PS
    Am J Health Syst Pharm; 2005 May; 62(9):905-16. PubMed ID: 15851496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ketolides and oxazolidinones. Mechanisms of action and antibacterial spectrum].
    Muller-Serieys C
    Presse Med; 2000 Dec; 29(37):2061-4. PubMed ID: 11155736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin derivatives): a new class of antibacterials highly potent against macrolide-resistant and -susceptible respiratory pathogens.
    Agouridas C; Denis A; Auger JM; Benedetti Y; Bonnefoy A; Bretin F; Chantot JF; Dussarat A; Fromentin C; D'Ambrières SG; Lachaud S; Laurin P; Le Martret O; Loyau V; Tessot N
    J Med Chem; 1998 Oct; 41(21):4080-100. PubMed ID: 9767644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.